Free Trial
NASDAQ:ENTX

Entera Bio (ENTX) Stock Price, News & Analysis

Entera Bio logo
$1.95 +0.04 (+2.09%)
As of 07/3/2025 03:26 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Entera Bio Stock (NASDAQ:ENTX)

Key Stats

Today's Range
$1.88
$1.96
50-Day Range
$1.82
$2.36
52-Week Range
$1.41
$2.79
Volume
18,161 shs
Average Volume
67,331 shs
Market Capitalization
$88.63 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$10.00
Consensus Rating
Buy

Company Overview

Entera Bio Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
41st Percentile Overall Score

ENTX MarketRank™: 

Entera Bio scored higher than 41% of companies evaluated by MarketBeat, and ranked 506th out of 922 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Entera Bio has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Entera Bio has received no research coverage in the past 90 days.

  • Read more about Entera Bio's stock forecast and price target.
  • Earnings Growth

    Earnings for Entera Bio are expected to decrease in the coming year, from ($0.28) to ($0.55) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Entera Bio is -7.50, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Entera Bio is -7.50, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Entera Bio has a P/B Ratio of 8.48. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Entera Bio's valuation and earnings.
  • Percentage of Shares Shorted

    0.18% of the float of Entera Bio has been sold short.
  • Short Interest Ratio / Days to Cover

    Entera Bio has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Entera Bio has recently decreased by 9.47%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Entera Bio does not currently pay a dividend.

  • Dividend Growth

    Entera Bio does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.18% of the float of Entera Bio has been sold short.
  • Short Interest Ratio / Days to Cover

    Entera Bio has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Entera Bio has recently decreased by 9.47%, indicating that investor sentiment is improving significantly.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Entera Bio this week, compared to 1 article on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Entera Bio insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    10.38% of the stock of Entera Bio is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 14.11% of the stock of Entera Bio is held by institutions.

  • Read more about Entera Bio's insider trading history.
Receive ENTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Entera Bio and its competitors with MarketBeat's FREE daily newsletter.

ENTX Stock News Headlines

Contrasting Entera Bio (NASDAQ:ENTX) & LAVA Therapeutics (NASDAQ:LVTX)
July 4th: 59% dividend from Bitcoin (No Crypto Needed)
I've got something exciting for you this July 4th holiday... How about a 59.07% dividend from Bitcoin? Yes, you read that right. And no, you don't need to buy any cryptocurrency or trade options... Here's the deal: Our July 4th special includes a FREE report on what I call the "Bitcoin Income Vault."
Entera Bio Reports Transformative Year in 2024
See More Headlines

ENTX Stock Analysis - Frequently Asked Questions

Entera Bio's stock was trading at $2.12 on January 1st, 2025. Since then, ENTX stock has decreased by 8.0% and is now trading at $1.95.

Entera Bio Ltd. (NASDAQ:ENTX) issued its quarterly earnings data on Friday, May, 9th. The company reported ($0.06) EPS for the quarter, topping analysts' consensus estimates of ($0.07) by $0.01. The business earned $0.04 million during the quarter. Entera Bio had a negative net margin of 4,525.11% and a negative trailing twelve-month return on equity of 95.10%.

Entera Bio (ENTX) raised $11 million in an IPO on Thursday, June 28th 2018. The company issued 1,400,000 shares at $8.00 per share. Maxim Group acted as the underwriter for the IPO and Joseph Gunnar was co-manager.

Shares of ENTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Entera Bio investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Adobe (ADBE), Advanced Micro Devices (AMD), CymaBay Therapeutics (CBAY) and GE Aerospace (GE).

Company Calendar

Last Earnings
5/09/2025
Today
7/06/2025
Next Earnings (Estimated)
8/08/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ENTX
Fax
N/A
Employees
20
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$10.00
High Stock Price Target
$10.00
Low Stock Price Target
$10.00
Potential Upside/Downside
+412.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$9.54 million
Net Margins
-4,525.11%
Pretax Margin
-4,518.83%

Debt

Sales & Book Value

Annual Sales
$223 thousand
Price / Cash Flow
N/A
Book Value
$0.23 per share
Price / Book
8.48

Miscellaneous

Free Float
40,734,000
Market Cap
$88.63 million
Optionable
Optionable
Beta
1.46
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

This page (NASDAQ:ENTX) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners